Diagnosis of X-linked myotubular myopathy by detection of myotubularin - PubMed (original) (raw)
Diagnosis of X-linked myotubular myopathy by detection of myotubularin
J Laporte et al. Ann Neurol. 2001 Jul.
Abstract
Mutations in the MTM1 gene cause X-linked recessive myotubular myopathy (XLMTM; MIM310400). Myotubularin, the implicated protein, is a phosphoinositide phosphatase that belongs to a large protein family conserved through evolution that also includes the antiphosphatase Sbfl and the protein hMTMR2 mutated in Charcot-Marie-Tooth type 4B. Myotubularin is detectable in a variety of cell lines by immunoprecipitation followed by Western blotting. We screened 29 independant patients with XLMTM phenotype and four with centronuclear myopathy. 87% (21/24) of patients with known MTM1 mutations showed abnormal myotubularin levels, including some with missense mutations. Moreover, myotubularin was also undetectable in a patient for whom no mutation could be identified by SSCP screening. The centronuclear cases investigated have a normal level of protein, suggesting that the centronuclear form is not the result of a decrease in myotubularin level. Thus, immunoprecipitation of myotubularin from cultured cells represents a rapid and helpful method for classifying those cases where no mutation was found. On the other hand, the amount of expression may be of diagnostic value for disease course in patients with a mutation.
Similar articles
- A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy.
Hammans SR, Robinson DO, Moutou C, Kennedy CR, Dennis NR, Hughes PJ, Ellison DW. Hammans SR, et al. Neuromuscul Disord. 2000 Feb;10(2):133-7. doi: 10.1016/s0960-8966(99)00073-5. Neuromuscul Disord. 2000. PMID: 10714588 - Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, Mandel JL. Blondeau F, et al. Hum Mol Genet. 2000 Sep 22;9(15):2223-9. doi: 10.1093/oxfordjournals.hmg.a018913. Hum Mol Genet. 2000. PMID: 11001925 - Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations.
Tosch V, Vasli N, Kretz C, Nicot AS, Gasnier C, Dondaine N, Oriot D, Barth M, Puissant H, Romero NB, Bönnemann CG, Heller B, Duval G, Biancalana V, Laporte J. Tosch V, et al. Neuromuscul Disord. 2010 Jun;20(6):375-81. doi: 10.1016/j.nmd.2010.03.015. Neuromuscul Disord. 2010. PMID: 20434914 - Interplay between myotubularins and Ca2+ homeostasis.
Dai N, Groenendyk J, Michalak M. Dai N, et al. Biochim Biophys Acta Mol Cell Res. 2024 Jun;1871(5):119739. doi: 10.1016/j.bbamcr.2024.119739. Epub 2024 May 6. Biochim Biophys Acta Mol Cell Res. 2024. PMID: 38710289 Review. - MTM1 mutations in X-linked myotubular myopathy.
Laporte J, Biancalana V, Tanner SM, Kress W, Schneider V, Wallgren-Pettersson C, Herger F, Buj-Bello A, Blondeau F, Liechti-Gallati S, Mandel JL. Laporte J, et al. Hum Mutat. 2000;15(5):393-409. doi: 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R. Hum Mutat. 2000. PMID: 10790201 Review.
Cited by
- Reducing dynamin 2 (DNM2) rescues _DNM2_-related dominant centronuclear myopathy.
Buono S, Ross JA, Tasfaout H, Levy Y, Kretz C, Tayefeh L, Matson J, Guo S, Kessler P, Monia BP, Bitoun M, Ochala J, Laporte J, Cowling BS. Buono S, et al. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):11066-11071. doi: 10.1073/pnas.1808170115. Epub 2018 Oct 5. Proc Natl Acad Sci U S A. 2018. PMID: 30291191 Free PMC article. - Congenital myopathies.
Bruno C, Minetti C. Bruno C, et al. Curr Neurol Neurosci Rep. 2004 Jan;4(1):68-73. doi: 10.1007/s11910-004-0015-7. Curr Neurol Neurosci Rep. 2004. PMID: 14683632 Review. - Centronuclear myopathies under attack: A plethora of therapeutic targets.
Tasfaout H, Cowling BS, Laporte J. Tasfaout H, et al. J Neuromuscul Dis. 2018;5(4):387-406. doi: 10.3233/JND-180309. J Neuromuscul Dis. 2018. PMID: 30103348 Free PMC article. Review. - Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
Gómez-Oca R, Cowling BS, Laporte J. Gómez-Oca R, et al. Int J Mol Sci. 2021 Oct 21;22(21):11377. doi: 10.3390/ijms222111377. Int J Mol Sci. 2021. PMID: 34768808 Free PMC article. Review. - Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS, Chevremont T, Prokic I, Kretz C, Ferry A, Coirault C, Koutsopoulos O, Laugel V, Romero NB, Laporte J. Cowling BS, et al. J Clin Invest. 2014 Mar;124(3):1350-63. doi: 10.1172/JCI71206. Epub 2014 Feb 24. J Clin Invest. 2014. PMID: 24569376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources